Medical Technology

The goal of Medip Analytics

The complex landscape of Biotech and Medtech is a challenge. At Medip Analytics, we're here to turn that challenge into an opportunity.

Our primary mission is to elevate medical companies by highlighting the unique benefits and value of their technology. We don't just offer software – we provide a comprehensive solution that empowers your business.

Harnessing evidence-based insights, we can make the compelling case for your medical technology's impact and value. Our specialty is in dynamic analytics of your technology with respect to effectiveness, health outcomes, costs (cost-effectiveness), and resource use. Our solutions are adaptable, whether your target is a local hospital, a key opinion leader, a payer, or a countrywide healthcare system, our software can show what matters for them.

Being dynamic is key for a rapid market adoption and will pave the way for increased sales and successful business outcomes. With Medip Analytics, transform challenges into opportunities and stay ahead in the competitive medical technology landscape.

Optimized Outcomes

Our Approach

At the heart of Medip Analytics lies "HEOR" – Health Economics and Outcomes Research. Utilizing this robust discipline, our strong scientific team, with over 10 years of experience and over 30 scientific publications, creates dynamic comparisons between your medical technology and current standards of care.

Through our simulation models, we envision a dual scenario – one where the current care prevails and another where your technology is used. Drawing from diverse data points including clinical studies, medical guidelines, financial factors, and quality of life indicators, we generate a comprehensive portrayal of your technology's value.

Health Economics

Over 12 years of experience in health technology assessment, software development and data-analytics

All the right tools for the dynamic assessment of the value of a technology:

Decision modeling


Decision-analytic modeling is a method in health technology assessments to assess the cost-effectiveness of a technology. This approach involves creating a model that simulates the potential outcomes and costs of using a particular technology, allowing decision makers to compare it to the current standard of care.

Software development


Traditional health technology assessments (HTAs) often take the form of a written report. With our interactive cloud software, you can easily demonstrate the value of a technology to stakeholders in different contexts. This allows you to show how the technology can benefit patients and healthcare organizations in a more dynamic and interactive way.

Bioinformatics, Statistics & Artificial Intelligence


Using predictive modeling on existing patient data can improve the accuracy and relevance of decision models. This approach allows the model to better reflect real-world scenarios and provide more precise predictions of the potential outcomes and costs of using a particular technology.

Our Experiences

Medip Analytics has a wide experience over technologies and disease areas.



  • Liquid biopsies
  • (Epi)genetic markers
  • Imaging techniques
  • Image-guided therapies
  • AI Algorithms
  • Devices
  • Implants
  • and more..


Disease areas

  • Airway infections
  • Bladder cancer
  • Breast cancer
  • Cardiac arrhythmias
  • Colorectal cancers
  • COPD
  • Dementia
  • Endometrial cancer
  • Endometriosis
  • Head and neck cancer
  • Leukemia
  • Lung cancer
  • Melanoma
  • Meniscus injuries
  • Prostate cancer
  • Schwannoma
  • Stroke detection
  • Ulcerative colitis
  • and more..


Scientific Publications

Ready to Unlock you product's potential?

Schedule a demo to see how Medip Software can drive your product's development and market success.



Noviotech Campus Building A

Transistorweg 7

6534 AT Nijmegen

The Netherlands

KVK: 84552735

BTW: NL863256776B01

IBAN: NL04 RABO 0376 1261 16


© 2024 Medip Analytics B.V. All Rights Reserved.